ASCENDIS PHARMA A/S's ticker is ASND and the CUSIP is 04351P101. A total of 143 filers reported holding ASCENDIS PHARMA A/S in Q1 2019. The put-call ratio across all filers is 0.49 and the average weighting 1.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2020 | $1,843,000 | +3.0% | 11,940 | -1.4% | 0.00% | 0.0% |
| Q2 2020 | $1,790,000 | -9.8% | 12,105 | -31.3% | 0.00% | 0.0% |
| Q1 2020 | $1,985,000 | -13.7% | 17,628 | +6.6% | 0.00% | 0.0% |
| Q4 2019 | $2,300,000 | +83.4% | 16,536 | +27.0% | 0.00% | 0.0% |
| Q3 2019 | $1,254,000 | -9.4% | 13,020 | +8.4% | 0.00% | 0.0% |
| Q2 2019 | $1,384,000 | +240.9% | 12,015 | +248.6% | 0.00% | -50.0% |
| Q1 2019 | $406,000 | – | 3,447 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| RA Capital Management | 4,240,536 | $300,484,000 | 16.06% |
| Sofinnova Investments, Inc. | 2,479,514 | $175,698,000 | 15.66% |
| Vivo Capital, LLC | 2,166,832 | $153,542,000 | 15.48% |
| VHCP Management II, LLC | 504,210 | $35,728,000 | 9.54% |
| EcoR1 Capital, LLC | 1,087,257 | $77,043,000 | 6.94% |
| Avoro Capital Advisors LLC | 1,963,336 | $139,122,000 | 6.39% |
| Foresite Capital Management IV, LLC | 245,424 | $17,391,000 | 5.70% |
| Eventide Asset Management | 1,544,900 | $109,472,000 | 4.02% |
| Orbimed Advisors | 4,155,891 | $294,486,000 | 3.55% |
| Ghost Tree Capital, LLC | 225,000 | $15,944,000 | 3.39% |